<bill session="115" type="s" number="204" updated="2019-07-16T21:20:09Z">
  <state datetime="2018-05-30">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2018-05-30"/>
  </status>
  <introduced datetime="2017-01-24"/>
  <titles>
    <title type="official" as="introduced">A bill to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes.</title>
    <title type="short" as="enacted">Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017</title>
    <title type="short" as="passed senate">Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017</title>
    <title type="short" as="passed senate">Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017</title>
    <title type="short" as="passed house">Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017</title>
    <title type="short" as="introduced">Trickett Wendler Right to Try Act of 2017</title>
    <title type="short" as="introduced">Trickett Wendler Right to Try Act of 2017</title>
    <title type="display">Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017</title>
  </titles>
  <sponsor bioguide_id="J000293"/>
  <cosponsors>
    <cosponsor bioguide_id="B001261" joined="2017-01-24"/>
    <cosponsor bioguide_id="B000575" joined="2017-01-24"/>
    <cosponsor bioguide_id="B001236" joined="2017-01-24"/>
    <cosponsor bioguide_id="B001135" joined="2017-02-07"/>
    <cosponsor bioguide_id="C001047" joined="2017-01-24"/>
    <cosponsor bioguide_id="C000567" joined="2017-01-24"/>
    <cosponsor bioguide_id="C001071" joined="2017-01-24"/>
    <cosponsor bioguide_id="C001095" joined="2017-01-24"/>
    <cosponsor bioguide_id="C000880" joined="2017-01-24"/>
    <cosponsor bioguide_id="C001098" joined="2017-01-24"/>
    <cosponsor bioguide_id="D000618" joined="2017-01-24"/>
    <cosponsor bioguide_id="D000607" joined="2017-01-24"/>
    <cosponsor bioguide_id="E000285" joined="2017-01-24"/>
    <cosponsor bioguide_id="F000463" joined="2017-01-24"/>
    <cosponsor bioguide_id="F000444" joined="2017-01-24"/>
    <cosponsor bioguide_id="G000562" joined="2017-01-24"/>
    <cosponsor bioguide_id="G000359" joined="2017-01-24"/>
    <cosponsor bioguide_id="G000386" joined="2017-01-24"/>
    <cosponsor bioguide_id="H000338" joined="2017-01-24"/>
    <cosponsor bioguide_id="H001041" joined="2017-01-24"/>
    <cosponsor bioguide_id="H001061" joined="2017-01-24"/>
    <cosponsor bioguide_id="I000024" joined="2017-01-24"/>
    <cosponsor bioguide_id="I000055" joined="2017-01-24"/>
    <cosponsor bioguide_id="K000393" joined="2017-01-24"/>
    <cosponsor bioguide_id="K000383" joined="2017-01-24"/>
    <cosponsor bioguide_id="L000575" joined="2017-01-24"/>
    <cosponsor bioguide_id="L000577" joined="2017-01-24"/>
    <cosponsor bioguide_id="M001183" joined="2017-01-24"/>
    <cosponsor bioguide_id="M000303" joined="2017-01-24"/>
    <cosponsor bioguide_id="M000355" joined="2017-01-24"/>
    <cosponsor bioguide_id="M000934" joined="2017-01-24"/>
    <cosponsor bioguide_id="M001153" joined="2017-01-24"/>
    <cosponsor bioguide_id="P000603" joined="2017-01-24"/>
    <cosponsor bioguide_id="P000612" joined="2017-01-24"/>
    <cosponsor bioguide_id="P000449" joined="2017-03-29"/>
    <cosponsor bioguide_id="R000584" joined="2017-01-24"/>
    <cosponsor bioguide_id="R000605" joined="2017-01-24"/>
    <cosponsor bioguide_id="R000595" joined="2017-01-24"/>
    <cosponsor bioguide_id="S001197" joined="2017-01-24"/>
    <cosponsor bioguide_id="S000320" joined="2017-01-24"/>
    <cosponsor bioguide_id="S001202" joined="2017-03-15"/>
    <cosponsor bioguide_id="S001198" joined="2017-01-24"/>
    <cosponsor bioguide_id="T000476" joined="2017-01-24"/>
    <cosponsor bioguide_id="T000461" joined="2017-01-24"/>
    <cosponsor bioguide_id="W000437" joined="2017-01-24"/>
    <cosponsor bioguide_id="Y000064" joined="2017-01-24"/>
  </cosponsors>
  <actions>
    <action datetime="2017-01-24">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-01-24" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2017-08-03">
      <text>Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.</text>
    </action>
    <action datetime="2017-08-03">
      <text>Measure laid before Senate by unanimous consent.</text>
      <reference ref="CR S4788-4789" label="consideration"/>
    </action>
    <vote how="by Unanimous Consent" type="vote" datetime="2017-08-03" where="s" result="pass" state="PASS_OVER:SENATE">
      <text>Passed Senate with an amendment by Unanimous Consent.</text>
    </vote>
    <action datetime="2017-08-03">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2017-08-04T13:05:19-04:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2017-08-04">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-08-11">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-05-21T21:28:11-04:00">
      <text>Rules Committee Resolution H. Res. 905 Reported to House. Rule provides for consideration of H.R. 5515, S. 204 and S. 2155. The resolution provides for one hour of general debate on H.R. 5515, S. 204 and S. 2155. The resolution provides for consideration of S. 2155 and S. 204 under a closed rule. Also, the resolution provides for consideration of H.R. 5515 under a structured rule and makes an amendment in the nature of a substitute consisting of the text of Rules Committee Print 115-70 considered as adopted.</text>
    </action>
    <action datetime="2018-05-22T15:52:15-04:00">
      <text>Considered under the provisions of rule H. Res. 905.</text>
      <reference ref="CR H4355-4366" label="consideration"/>
    </action>
    <action datetime="2018-05-22T15:52:20-04:00">
      <text>Rule provides for consideration of H.R. 5515, S. 204 and S. 2155. The resolution provides for one hour of general debate on H.R. 5515, S. 204 and S. 2155. The resolution provides for consideration of S. 2155 and S. 204 under a closed rule. Also, the resolution provides for consideration of H.R. 5515 under a structured rule and makes an amendment in the nature of a substitute consisting of the text of Rules Committee Print 115-70 considered as adopted.</text>
    </action>
    <action datetime="2018-05-22T15:52:52-04:00">
      <text>DEBATE - The House proceeded with one hour of debate on S. 204.</text>
    </action>
    <action datetime="2018-05-22T16:42:53-04:00">
      <text>The previous question was ordered pursuant to the rule.</text>
    </action>
    <action datetime="2018-05-22T16:43:31-04:00">
      <text>Ms. Schakowsky moved to recommit with instructions to the Committee on Energy and Commerce.</text>
      <reference ref="CR H4363"/>
    </action>
    <action datetime="2018-05-22T16:43:45-04:00">
      <text>DEBATE - The House proceeded with 10 minutes of debate on the motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to strike everything after section 1 and insert a completely new text.</text>
    </action>
    <action datetime="2018-05-22T16:50:56-04:00">
      <text>The previous question on the motion to recommit with instructions was ordered without objection.</text>
    </action>
    <action datetime="2018-05-22T17:19:02-04:00">
      <text>On motion to recommit with instructions Failed by the Yeas and Nays: 187 - 231 (Roll no. 213).</text>
    </action>
    <vote how="roll" type="vote2" roll="214" datetime="2018-05-22T17:26:52-04:00" where="h" result="pass" state="PASSED:BILL">
      <text>On passage Passed by recorded vote: 250 - 169 (Roll no. 214).</text>
      <reference ref=" CR H4355-4356" label="text"/>
    </vote>
    <action datetime="2018-05-22T17:26:54-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <topresident datetime="2018-05-24">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2018-05-30" state="ENACTED:SIGNED">
      <text>Signed by President.</text>
    </signed>
    <enacted number="115-176" type="public" datetime="2018-05-30">
      <text>Became Public Law No: 115-176.</text>
    </enacted>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Discharged, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="878"/>
    <bill type="h" session="115" relation="unknown" number="5247"/>
    <bill type="h" session="115" relation="unknown" number="2368"/>
    <bill type="hr" session="115" relation="unknown" number="905"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Civil actions and liability"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Long-term, rehabilitative, and terminal care"/>
    <term name="Prescription drugs"/>
    <term name="Product safety and quality"/>
  </subjects>
  <amendments>
    <amendment number="s753"/>
  </amendments>
  <summary date="2018-05-31T03:59:59Z" status="Public Law">Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

(Sec.2)This bill amends the Federal Food, Drug, and Cosmetic Act to exempt,&#160;from&#160;specified requirements and restrictions under that Act and other laws, the provision of certain unapproved, investigational drugs to a terminally ill patient who has exhausted approved treatment options and&#160;is unable to participate in a clinical trial involving the drugs. The manufacturer or sponsor of an eligible investigational drug must report annually to the Food and Drug Administration (FDA) on any use of&#160;the drug in accordance with these provisions. The FDA shall post an annual summary report of such use on its website.

The bill limits&#160;the liability of&#160;a sponsor, manufacturer, prescriber,&#160;or dispenser that provides, or declines to provide, an eligible investigational drug to an eligible patient in accordance with the bill.</summary>
  <committee-reports/>
</bill>
